Antinuclear antibodies with the homogeneous pattern (ANA-H) and smooth muscle antibodies with antiactin specificity (SMA-AA) are regarded as the serum markers of type-i autoimmune chronic hepatitis. Their diagnostic relevance, however, has been questioned recently after the detection of signs of hepatitis C virus infection in autoimmune chronic hepatitis patients. To further evaluate this point, antihepatitis C virus antibodies were sought by two second generation assays
Abstract
Antinuclear antibodies with the homogeneous pattern (ANA-H) and smooth muscle antibodies with antiactin specificity (SMA-AA) are regarded as the serum markers of type-i autoimmune chronic hepatitis. Their diagnostic relevance, however, has been questioned recently after the detection of signs of hepatitis C virus infection in autoimmune chronic hepatitis patients. To further evaluate this point, antihepatitis C virus antibodies were sought by two second generation assays (ELISA 2 and RIBA 2) in 100 Italian patients with chronic liver disease of unknown aetiology, including 46 with (autoimmune chronic hepatitis) and 54 without the above antibodies (cryptogenic). By ELISA 2, antihepatitis C virus, although significantly prevalent in cryptogenic (83%), were found also in a substantial proportion of autoimmune chronic hepatitis patients (46%) (p<0.0001), their occurrence was confirmed by RIBA 2 in almost all cases (96% and 86%, respectively).
Autoimmune patients with either ANA-H or SMA-AA exhibited similar antihepatitis C virus prevalences (59% and 52%, respectively); by contrast, the eight cases positive for both the autoantibodies were consistently antihepatitis C virus negative. These findings confirm that in countries with high hepatitis C virus circulation (like Italy) an overlap between autoimmune chronic hepatitis and hepatitis C virus infection, reflected by 'true' antihepatitis C virus antibodies, does occur. The detection of ANA-H or SMA-AA, in fact, identifies chronic liver disease patients with a relatively low prevalence of antihepatitis C virus, but does not exclude hepatitis C virus infection. Positive findings for both ANA-H and SMA-AA, however, is an appropriate marker for hepatitis C virus free 'primary' autoimmune chronic hepatitis. out to be also positive for antihepatitis C virus. 8 This confirmed a previous report from Spain.9 In order to test the diagnostic relevance of ANA-H and SMA-AA as markers of type-i autoimmune chronic hepatitis we applied two commercially available second generation tests for detecting antihepatitis C virus antibodies: an ELISA and an immunoblot assay (both from Ortho-Chiron), which detect antibodies to nonstructural and structural hepatitis C virus recombinant peptides. As controls, cryptogenic cases of chronic liver disease -that is, without ANA-H or SMA-AA, were similarly studied.
Methods

PATIENTS AND SERA
Serum samples from 100 patients with chronic liver disease of unknown aetiology were studied: 46 with autoimmune chronic hepatitis and 54 with cryptogenic chronic liver disease. The diagnosis of chronic liver disease was made by accepted clinical, serological and histological criteria.'`Clinical and biochemical parameters are reported in Table I . Hepatitis B virus infection was excluded on the basis of radioimmunoassay negativity for serological markers (HBsAg, HBeAg, anti HBs, anti HBc, and anti HBe). In the cases studied alcohol intake was never higher than 50 g/day. Alpha-i antitrypsin deficiency and Wilson disease were excluded by determining serum concentrations of alpha-i antitrypsin and ceruloplasmin, respectively. Intake of potentially hepatotoxic drugs, intravenous drug addiction and previous blood transfusions were ruled out in all patients. All autoimmune patients exhibited serum ANA-H and/or SMA-AA; they were in a different phase of treatment with methylprednisolone at the moment of antihepatitis C virus testing. All cryptogenic patients were negative for ANA-H, SMA-AA as well as liver-kidney microsomal antibody.
AUTOANTIBODY TESTING Sera, diluted 1:40, were tested by immunofluorescence using both cryostat tissue (rat liver, stomach, and kidney) sections and HEp-2 cell cultures (Kallestad, Austin, Texas, USA) as substrates. Liver sections of rats chronically intoxicated with phalloidin were also used, as previously described." Antibodies to muscle actin were also searched for by counterimmunoelectrophoresis using rabbit muscle actin as antigen."`Sera were scored as positive for Table III . By ELISA 2, the prevalence of antihepatitis C virus positivity was similar in the subgroups with isolated ANA-H or SMA-AA; by contrast, all the eight patients positive for both SMA-AA and ANA-H were antihepatitis C virus negative. The three autoimmune cases positive by ELISA 2 and negative by RIBA 2 were all in the SMA-AA subgroup.
The relevant clinical, biochemical, and histological data of autoimmune patients, divided according to the antihepatitis C virus and autoantibody status, are reported in Table IV . From its analysis it appears that the eight antihepatitis C virus negative patients with both ANA-H and SMA-AA had significantly higher values of serum gamma globulins than those with either ANA-H or SMA-AA, irrespectively to the antihepatitis C virus result. Moreover, they were all women, had a lower age and higher serum glutamic oxalo acetic transaminase concentrations. These differences, however, did not reach statistical significance. Discussion Apart from the recognition and prevention of non-A-non-B post transfusion hepatitis, the availability of reliable tests for the demonstration of circulating antibodies to hepatitis C virus peptides has made it possible to address a number of yet unresolvred problems as the aetiology of cryptogenic chronic liver disease and the role of hepatitis C virus in cases with other known risk factors (hepatitis B virus, alcohol). Of particular interest is the relationship between autoimmune chronic hepatitis and hepatitis C virus infection. This study, carried out in an Italian series of patients accurately selected for the absence of other known aetiologic factors, and the presence of well established serum markers of autoimmunity, confirms previous observations made with a first generation ELISA55 that a wide overlap between the two above conditions does occur. Using a second generation ELISA (which allows to detect antibodies to both non-structural and structural peptides), antihepatitis C virus prevalence in type-i autoimmune chronic hepatitis, although significantly lower than that of cryptogenic chronic liver disease cases, was still as high as 46%. It is pertinent to recall that an even higher antihepatitis C virus prevalence has been found in type-2 (liver-kidney microsomal positive) autoimmune chronic hepatitis.'4 Moreover, two thirds of the liver-kidney microsomal positive cases had serum hepatitis C virus-RNA, as judged from the positivity of sensitive 'nested' PCR. '> The fact that most ELISA 2 positive cases here detected, both in autoimmune chronic hepatitis and cryptogenic chronic liver disease, were also reactive by RIBA 2 confirms the true immune nature of the antihepatitis C virus result. It is difficult to interpret the higher RIBA 2 frequency of anti c33c and the higher RIBA 2 scores of both anti c33c and c22-3 antibodies in the cryptogenic group, as information on the temporal sequence and significance of the immune response to each viral peptide is lacking at present.
From the above results it appears that the positivity of either ANA-H or SMA-AA, although significantly associated with signs of marked immune stimulation (higher hypergammaglobulinemia Table I ), does not allow to rule out a coexistent hepatitis C virus infection.
Interestingly, however, none of the eight cases with both ANA-H and SMA-AA was antihepatitis C virus positive by ELISA 2: this was significantly different from that found in cases positive for either reactivity (ANA-H or SMA-AA). If confirmed in a larger number of cases, this would support the hypothesis that the above autoimmune profile is particularly relevant in the positive diagnosis of autoimmune chronic hepatitis. In line with this hypothesis, classical features of autoimmune hepatitis were predominant in these eight patients: female sex, young age, high glutamic oxalo acetic transminase and gamma globulin levels (Table IV 
